Skip to main content
Mereo BioPharma Group plc (AIM:MPH)
London flag London · Delayed Price · Currency is GBP · Price in GBX
26.50
-0.50 (-1.85%)
At close: Dec 17, 2020

Mereo BioPharma Group Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-41.88-43.25-29.47-42.2217.23
Upgrade
Depreciation & Amortization
1.151.091.060.890.87
Upgrade
Loss (Gain) From Sale of Assets
-----0.15
Upgrade
Stock-Based Compensation
7.67.394.924.774.47
Upgrade
Other Operating Activities
5.362.313.94-9.91-27.01
Upgrade
Change in Accounts Receivable
-----0.8
Upgrade
Change in Accounts Payable
-1.380.15-1.260.62-1.7
Upgrade
Change in Other Net Operating Assets
-1.83-0.52-0.33-2.97-
Upgrade
Operating Cash Flow
-30.97-32.83-21.13-48.82-7.09
Upgrade
Capital Expenditures
-0.02---0.01-0.72
Upgrade
Sale (Purchase) of Intangibles
--0.7-0.4220.15
Upgrade
Other Investing Activities
----0
Upgrade
Investing Cash Flow
-0.02-0.7-0.421.99-0.57
Upgrade
Long-Term Debt Repaid
---3.19--0.94
Upgrade
Net Debt Issued (Repaid)
---3.19--0.94
Upgrade
Issuance of Common Stock
0.534711.61-106.4
Upgrade
Other Financing Activities
-0.2-0.85-0.440.2-0.32
Upgrade
Financing Cash Flow
0.3346.157.970.2105.15
Upgrade
Foreign Exchange Rate Adjustments
1.85-0.232.82-12.58-1.58
Upgrade
Miscellaneous Cash Flow Adjustments
---0--
Upgrade
Net Cash Flow
-28.8112.38-10.76-59.2295.9
Upgrade
Free Cash Flow
-30.99-32.83-21.13-48.83-7.82
Upgrade
Free Cash Flow Margin
-6198.20%--211.32%--15.83%
Upgrade
Free Cash Flow Per Share
-0.19-0.22-0.16-0.41-0.07
Upgrade
Cash Interest Paid
0.030.020.880.02-
Upgrade
Cash Income Tax Paid
---1.341.88-
Upgrade
Levered Free Cash Flow
-18.1-21.5-14.17-32.74-9.08
Upgrade
Unlevered Free Cash Flow
-17.94-20.64-12.37-30.13-5.88
Upgrade
Change in Working Capital
-3.2-0.37-1.59-2.35-2.5
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.